{
  "docId": "019de073-152c-71a8-85ee-4569efdf59ee",
  "docSlug": "7213c6821ef7b57b467d708a4eb22d62",
  "documentTitle": "Alkermes | Results Presentation Deck | 15 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 15,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 10,
  "notes": "The chart displays TRx MOT (Total Prescriptions Months of Therapy).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-152c-71a8-85ee-4569efdf59ee/9",
  "deckHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee",
  "deckJsonHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee.json",
  "deckAnchorHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.55,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "ARISTADA Quarterly TRx MOT",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e6387b2-d4fc-4caa-97ea-33ba06a02148",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.25
      },
      "kind": "list",
      "text": "Q2'22 year-over-year growth of 11% on TRx months of therapy (MOT) basis; Outpaced overall atypical long-acting injectable (LAI) market Q2'22 year-over-year growth of 7%; Market share: TRx MOT: 10% of atypical LAI market prescriptions in Q2'22",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8801c03-203c-4939-9585-2900941a40f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: IQVIA NPA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79416422-e9e2-4094-95e6-74ba1cebedc1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "ARISTADA® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb1802cc-2dae-4ae3-9025-0d9555ff55e2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 4,
      "beatId": "f1bcf930-f5e7-4bd4-b57d-cf814f3523c2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Financial Results Summary",
      "beatSlug": null,
      "evidence": "Slides 4-11 provide detailed overviews of financial results and product performance",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}